Unlabelled: Eyelid tumors are the most common neoplasms in everyday ophthalmic practice and cover a wide range of benign and malignant lesions. Surgical methods, cryodestruction, laser therapy and radiation therapy are used in the treatment of malignant eyelid tumors. Chemotherapy does not occupy a prominent place in the treatment of malignant eyelid tumors, its use is limited to sensitive tumors.
View Article and Find Full Text PDFPlasmonic nanocomposites ZnO-Ag and ZnO-SnO-Ag(AgCl) were prepared by the polymer-salt method, and their structure and morphology were studied using XRD and SEM analyses. It was found that the addition of photoactive inorganic nanocomposites ZnO-Ag and ZnO-SnO-Ag(AgCl) in pure water significantly enhances the effectiveness of its disinfection and purification during UV treatment and provides the effective water oxygenation. Oxygen photogeneration under blue light (λ = 405 nm) can be related to the plasmon-excitation processes in ZnO-SnO-Ag(AgCl) composites.
View Article and Find Full Text PDFA systematic review of the studies where HIPEC combined with cytoreductive surgery was used in patients with primary advanced ovarian cancer was performed to understand is there a role for this treatment modality not only in recurrent but in primary advanced ovarian cancer. The results are controversial but there is a strong trend for improvement of the long-term outcomes of patients with primary advanced ovarian cancer after HIPEC.
View Article and Find Full Text PDFPatol Fiziol Eksp Ter
December 2017
Int J Hyperthermia
August 2018
Objectives: The choice of an optimal administration route for intraperitoneal (IP) chemotherapy and a suitable chemotherapeutic regime in the treatment of ovarian cancer remains a controversy. We investigated survival outcomes according to catheter intraperitoneal chemotherapy (CIPC), normothermic and hyperthermic chemoperfusion (NIPEC and HIPEC) with cytostatic drugs dioxadet and cisplatin in rats with transplantable ascitic ovarian cancer.
Methods: Ascitic liquid containing 1 × 10 tumour cells was inoculated to female Wistar rats and 48 hours after rats received dioxadet and cisplatin at the maximum tolerated doses.